BioSpace News Archive

Genetown

CENTOGENE Reveals Growth of Rare Hereditary Disease Knowledge Base

CENTOGENE revealed the growth in its knowledge-base of rare hereditary diseases.

July 1, 2019
·
2 min read
Bittium Wearable Platform with Philips EmoGraphy & CardioSense Solution Was Awarded in the GSK’s “Transform the Future of Self-Care” Innovation Contest

Bittium Wearable Platform with Philips EmoGraphy & CardioSense Solution Was Awarded in the GSK’s “Transform the Future of Self-Care” Innovation Contest

July 1, 2019
·
3 min read
Deals

Novartis successfully completes acquisition of Xiidra®, bolstering ophthalmic portfolio

Novartis announced that it has completed its acquisition of Xiidra® 5%, the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease.

July 1, 2019
·
5 min read
ANDOZ makes SYMJEPI™ (epinephrine) 0.3 mg Injection donation to Americares

Sandoz announced its donation of over 4,000 packs of SYMJEPI™ 0.3 mg Injection for immediate use in free and charity clinics in the US through its collaboration with Americares.

July 1, 2019
·
5 min read
Business

Century Therapeutics Launches with $250 Million for Induced Pluripotent Stem Cell Platform

Century’s iPSCs, which are stem cells that can be generated from adult stem cells, have unlimited self-renewing capacity, the company said, which enables multiple rounds of cellular engineering.

July 1, 2019
·
2 min read
·
Alex Keown
Business

Amicus Inks Deal with Thermo Fisher’s Brammer Bio

Under the agreement, Thermo Fisher will provide Amicus with immediate clinical and commercial manufacturing capabilities and capacity for Amicus’ intrathecal AAV Batten disease gene therapy programs.

July 1, 2019
·
3 min read
·
Mark Terry
Drug Development

FDA Action Alert: Karyopharm, Merck and Celgene

The month of July is a slow one for the U.S. Food and Drug Administration (FDA), at least in terms of scheduled approval dates. Here’s a look at the three PDUFA dates the agency has on its calendar for the month.

July 1, 2019
·
2 min read
·
Mark Terry
Drug Development

Biogen Adds Data in Support of Spinraza for Spinal Muscular Atrophy

Now that Novartis has a competing therapy on the market for spinal muscular atrophy (SMA), Biogen is eager to show why it thinks its Spinraza (nusinersen) is superior.

July 1, 2019
·
3 min read
·
Mark Terry
Career Advice

Top Life Science Companies Hiring Now in July

According to a BioSpace poll, over half (56%) of respondents are not happy with their current life sciences position. Are you one of the 56%? You deserve to be happy! Start working towards your happiness and check out job opportunities at these top companies!

July 1, 2019
·
1 min read
·
BioSpace Staff
Policy

Life Science Company Launches New Quality Supplier Website

FDA Quality and Regulatory Consultants and its sister company, Solar Compliance have announced a unique tool to help in the due diligence and qualification of outsourced partners, The Orange Report.

July 1, 2019
·
2 min read